This study evaluated fibulin-3 levels in plasma among patients with malignant pleural mesothelioma (MPM), benign pleural conditions, and metastatic pleural carcinomatosis, addressing the diagnostic challenge posed by overlapping clinical presentations and examination results. Here, EFEMP1 is linked to malignant pleural mesothelioma.